| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/10/2004 | US20040110822 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110762 inhibitors of protein tyrosine kinase and are antiproliferative agents; 4-(4-phenoxyanilino)benzo[g]quinoline-3-carbonitrile for example; chemical intermediates, synthesis; treating polycystic kidney disease, colon polyps, cancer |
| 06/10/2004 | US20040110760 Nitro and amino substituted topoisomerase agents |
| 06/10/2004 | US20040110752 2-amino-5-((hetero)aryl)-thiazole derivatives; treatment of disorders such as cancer, immunologic disorders and allergic disorders, optionally in combination with other drugs such as immunosuppressants |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/10/2004 | US20040110229 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence |
| 06/10/2004 | CA2506524A1 Pyrazoloquinolines with immunomodulating activity |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1425355A1 A compressed fluid formulation |
| 06/09/2004 | EP1425286A1 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of diseases |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425283A1 Novel 4-aminofuropyrimidines and the use thereof |
| 06/09/2004 | EP1425282A2 Process for the preparation of diketopyrrolopyrroles |
| 06/09/2004 | EP1286998B1 Oxazolidinone derivatives with antibiotic activity |
| 06/09/2004 | EP0892786B1 New carboxylic acid derivatives, their production and use |
| 06/09/2004 | CN1503801A Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 06/09/2004 | CN1503800A antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 06/09/2004 | CN1503786A Large conductance calcium-activated k channel opener |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 06/08/2004 | US6747154 Process for preparing scopine esters |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747032 Pyrimidin-4-one compounds |
| 06/08/2004 | US6747023 Sulfonyl derivatives |
| 06/08/2004 | US6746990 Insecticides, acaricides and herbicides |
| 06/03/2004 | WO2004045562A2 Mixed kappa/mu opioids and uses thereof |
| 06/03/2004 | WO2004022542A3 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106830 Method of synthesizing camptothecin-relating compounds |
| 06/03/2004 | US20040106661 Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 06/03/2004 | US20040106642 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 06/03/2004 | US20040106639 CCR1 antagonists and methods of use therefor |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106609 Pyranoindazoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040105907 Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423123A1 Tetracyclic indole derivatives as 5-ht receptor ligands |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP0769966B1 Biotin compounds for targetting tumors and sites of infection |
| 06/02/2004 | CN1500787A Cyclic nitrones and pharmaceutical compositions containing them |
| 06/02/2004 | CN1500779A Cyclic nitrones and pharmaceutical compositions containing them |
| 06/02/2004 | CN1152040C Carbazole derivatives, preparing process thereof and pharmaceutical combination containing the same |
| 06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743918 Process for producing camptothecin |
| 06/01/2004 | US6743917 Camptothecin analogs and methods of preparation thereof |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 05/27/2004 | WO2004044174A2 Topoisomerase-targeting agents |
| 05/27/2004 | WO2004043967A1 Spirocyclic cyclohexane derivatives |
| 05/27/2004 | WO2004043966A1 New tricyclic derivatives as ltd4 antagonists |
| 05/27/2004 | WO2004043965A1 Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease |
| 05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043927A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 05/27/2004 | WO2004043392A2 Mucin synthesis inhibitors |
| 05/27/2004 | WO2003010175A3 Radiolabeled neuropeptide y y5 receptor antagonists |
| 05/27/2004 | US20040102491 Antimicrobial agents |
| 05/27/2004 | US20040102443 Nitro and amino substituted topoisomerase agents |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102327 Pesticides, herbicides; spiropyran-pyrroline-2-one deriva-tives |
| 05/27/2004 | DE10252667A1 New spiro-((cyclohexane)-tetrahydropyrano-(3,4-b)-indole) derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain |
| 05/27/2004 | CA2510337A1 Topoisomerase-targeting agents |
| 05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | CA2505557A1 Mucin synthesis inhibitors |
| 05/27/2004 | CA2505491A1 New tricyclic derivatives as ltd4 antagonists |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421086A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY |
| 05/26/2004 | EP1421074A1 Novel compounds |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420747A2 Benzoquinone ansamycins |
| 05/26/2004 | EP1420644A1 Substituted propargylamines |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 05/25/2004 | US6740756 Fluorescent lanthanide chelates |
| 05/25/2004 | US6740674 Administering formulation comprising proteasome inhibitor in carrier for therapy of dry eye disorder |
| 05/25/2004 | US6740650 Heterocyclic cytotoxic agents |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/21/2004 | WO2004042117A1 Process for electrochemical oxidation of ferrocyanide to ferricyanide |
| 05/21/2004 | WO2004042116A1 Process for electrochemical oxidation of ferrocyanide to ferricyanide |
| 05/21/2004 | WO2004041829A1 Quinazoline derivatives as src tyrosine kinase inhibitors |
| 05/21/2004 | WO2004041823A1 Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| 05/21/2004 | WO2004041285A1 Antiinflammation agents |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |